Differential roles of galectin-1 and galectin-3 in regulating leukocyte viability and cytokine secretion

Journal of Immunology

Volumn 180, Issue 5, 2008, Pages 3091-3102

  Stowell, Sean R ^a   Qian, Yuning ^b   Karmakar, Sougata ^c   Koyama, Natalia S ^d   Dias Baruffi, Marcelo ^d   Leffler, Hakon ^b   McEver, Rodger P ^c   Cummings, Richard D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUND UNIVERSITY   (Sweden)

^c OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; GALECTIN 1; GALECTIN 3; GAMMA INTERFERON; INTERLEUKIN 10; PHOSPHATIDYLSERINE; T LYMPHOCYTE RECEPTOR; CYTOKINE; LGALS1 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BINDING AFFINITY; CALCIUM CELL LEVEL; CELL DEATH; CELL SURFACE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IN VIVO STUDY; LEUKOCYTE; MOLECULAR INTERACTION; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; REGULATORY MECHANISM; T LYMPHOCYTE ACTIVATION; BIOSYNTHESIS; CELL SURVIVAL; COMPARATIVE STUDY; CYTOLOGY; IMMUNOLOGY; LEUKOCYTE ACTIVATION; LYMPHOCYTE ACTIVATION; PHYSIOLOGY; SECRETION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR CELL LINE;

CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; CYTOKINES; GALECTIN 1; GALECTIN 3; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; NEUTROPHIL ACTIVATION; NEUTROPHILS; PHOSPHATIDYLSERINES; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 46949103440     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.5.3091     Document Type: Article

References (79)

1. Bauer, A., A. Villunger, V. Labi, S. F. Fischer, A. Strasser, H. Wagner, R. M. Schmid, and G. Hacker. 2006. The NF-κB regulator Bcl-3 and the BH3-only proteins Bim and Puma control the death of activated T cells. Proc. Natl. Acad. Sci. USA 103: 10979-10984.
2. Strasser, A. 2005. The role of BH3-only proteins in the immune system. Nat. Rev. Immunol. 5: 189-200.
3. Henson, P. M., and R. B. Johnston, Jr. 1987. Tissue injury in inflammation: oxidants, proteinases, and cationic proteins. J. Clin. Invest. 79: 669-674.
4. Nathan, C. 2006. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 6: 173-182.
5. Simon, H. U. 2003. Neutrophil apoptosis pathways and their modifications in inflammation. Immunol. Rev. 193: 101-110.
6. Iwai, K., T. Miyawaki, T. Takizawa, A. Konno, K. Ohta, A. Yachie, H. Seki, and N. Taniguchi. 1994. Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 84: 1201-1208.
7. Fecho, K., S. A. Bentley, and P. L. Cohen. 1998. Mice deficient in fas ligand (gld) or fas (lpr) show few alterations in granulopoiesis. Cell. Immunol. 188: 19-32.
8. Jackson, C. E., R. E. Fischer, A. P. Hsu, S. M. Anderson, Y. Choi, J. Wang, J. K. Dale, T. A. Fleisher, L. A. Middelton, M. C. Sneller, et al. 1999. Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance. Am. J. Hum. Genet. 64: 1002-1014.
9. Kwon, S. W., J. Procter, J. K. Dale, S. E. Straus, and D. F. Stroncek. 2003. Neutrophil and platelet antibodies in autoimmune lymphoproliferative syndrome. Vox Sang. 85: 307-312.
10. Fecho, K., and P. L. Cohen. 1998. Fas ligand (gld)- and Fas (lpr)-deficient mice do not show alterations in the extravasation or apoptosis of inflammatory neutrophils. J. Leukocyte Biol. 64: 373-383.
11. Shi, J., G. E. Gilbert, Y. Kokubo, and T. Ohashi. 2001. Role of the liver in regulating numbers of circulating neutrophils. Blood 98: 1226-1230.
12. Lagasse, E., and I. L. Weissman. 1994. bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages. J. Exp. Med. 179: 1047-1052.
13. Levi, G., R. Tarrab-Hazdai, and V. I. Teichberg. 1983. Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits. Eur. J. Immunol. 13: 500-507.
14. Baum, L. G., D. P. Blackall, S. Arias-Magallano, D. Nanigian, S. Y. Uh, J. M. Browne, D. Hoffmann, C. E. Emmanouilides, M. C. Territo, and G. C. Baldwin. 2003. Amelioration of graft versus host disease by galectin-1. Clin. Immunol. 109: 295-307.
15. Santucci, L., S. Fiorucci, N. Rubinstein, A. Mencarelli, B. Palazzetti, B. Federici, G. A. Rabinovich, and A. Morelli. 2003. Galectin-1 suppresses experimental colitis in mice. Gastroenterology 124: 1381-1394.
16. Santucci, L., S. Fiorucci, F. Cammilleri, G. Servillo, B. Federici, and A. Morelli. 2000. Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice. Hepatology 31: 399-406.
17. Rubinstein, N., J. M. Ilarregui, M. A. Toscano, and G. A. Rabinovich. 2004. The role of galectins in the initiation, amplification and resolution of the inflammatory response. Tissue Antigens 64: 1-12.
18. La, M., T. V. Cao, G. Cerchiaro, K. Chilton, J. Hirabayashi, K. Kasai, S. M. Oliani, Y. Chernajovsky, and M. Perretti. 2003. A novel biological activity for galectin-1: inhibition of leukocyte-endothelial cell interactions in experimental inflammation. Am. J. Pathol. 163: 1505-1515.
19. Sano, H., D. K. Hsu, J. R. Apgar, L. Yu, B. B. Sharma, I. Kuwabara, S. Izui, and F. T. Liu. 2003. Critical role of galectin-3 in phagocytosis by macrophages. J. Clin. Invest. 112: 389-397.
20. + T cells. Blood 109: 2058-2065.
21. + regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function. Blood 110: 1550-1558.
22. Rabinovich, G. A., L. G. Baum, N. Tinari, R. Paganelli, C. Natoli, F. T. Liu, and S. Iacobelli. 2002. Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? Trends Immunol. 23: 313-320.
23. Perillo, N. L., K. E. Pace, J. J. Seilhamer, and L. G. Baum. 1995. Apoptosis of T cells mediated by galectin-1. Nature 378: 736-739.
24. Pace, K. E., H. P. Hahn, and L. G. Baum. 2003. Preparation of recombinant human galectin-1 and use in T-cell death assays. Methods Enzymol. 363: 499-518.
25. Schlegel, R. A., and P. Williamson. 2001. Phosphatidylserine, a death knell. Cell Death Differ. 8: 551-563.
26. Stowell, S. R., S. Karmakar, C. J. Stowell, M. Dias-Baruffi, R. P. McEver, and R. D. Cummings. 2007. Human galectin-1, -2, and -4 induce surface exposure of phosphatidylserine in activated human neutrophils but not in activated T cells. Blood 109: 219-227.
27. Henson, P. M., and D. A. Hume. 2006. Apoptotic cell removal in development and tissue homeostasis. Trends Immunol. 27: 244-250.
28. Wu, Y., N. Tibrewal, and R. B. Birge. 2006. Phosphatidylserine recognition by phagocytes: a view to a kill. Trends Cell Biol. 16: 189-197.
29. Dias-Baruffi, M., H. Zhu, M. Cho, S. Karmakar, R. P. McEver, and R. D. Cummings. 2003. Dimeric galectin-1 induces surface exposure of phosphatidylserine and phagocytic recognition of leukocytes without inducing apoptosis. J. Biol. Chem. 278: 41282- 41293.
30. 2+ to galectin-1-induced exposure of phosphatidylserine on activated neutrophils. J. Biol. Chem. 280: 28623-28631.
31. Dumic, J., S. Dabelic, and M. Flogel. 2006. Galectin-3: an open-ended story. Biochim. Biophys. Acta 1760: 616-635.
32. Stillman, B. N., D. K. Hsu, M. Pang, C. F. Brewer, P. Johnson, F. T. Liu, and L. G. Baum. 2006. Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death. J. Immunol. 176: 778-789.
33. Fukumori, T., Y. Takenaka, T. Yoshii, H. R. Kim, V. Hogan, H. Inohara, S. Kagawa, and A. Raz. 2003. CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. Cancer Res. 63: 8302-8311.
34. Ahmad, N., H. J. Gabius, S. Andre, H. Kaltner, S. Sabesan, R. Roy, B. Liu, F. Macaluso, and C. F. Brewer. 2004. Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes. J. Biol. Chem. 279: 10841-10847.
35. Murray, J. I., M. L. Whitfield, N. D. Trinklein, R. M. Myers, P. O. Brown, and D. Botstein. 2004. Diverse and specific gene expression responses to stresses in cultured human cells. Mol. Biol. Cell 15: 2361-2374.
36. 2+ homeostasis. J. Cell Biol. 157: 1017-1028.
37. Braakman, I., J. Helenius, and A. Helenius. 1992. Manipulating disulfide bond formation and protein folding in the endoplasmic reticulum. EMBO J. 11: 1717-1722.
38. Tartier, L., Y. L. McCarey, J. E. Biaglow, I. E. Kochevar, and K. D. Held. 2000. Apoptosis induced by dithiothreitol in HL-60 cells shows early activation of caspase 3 and is independent of mitochondria. Cell Death Differ. 7: 1002-1010.
39. van den Brule, F., S. Califice, F. Garnier, P. L. Fernandez, A. Berchuck, and V. Castronovo. 2003. Galectin-1 accumulation in the ovary carcinoma peritumoral stroma is induced by ovary carcinoma cells and affects both cancer cell proliferation and adhesion to laminin-1 and fibronectin. Lab. Invest. 83: 377-386.
40. Kaltner, H., K. Seyrek, A. Heck, F. Sinowatz, and H. J. Gabius. 2002. Galectin-1 and galectin-3 in fetal development of bovine respiratory and digestive tracts: comparison of cell type-specific expression profiles and subcellular localization. Cell Tissue Res. 307: 35-46.
41. Whitney, P. L., J. T. Powell, and G. L. Sanford. 1986. Oxidation and chemical modification of lung β-galactoside-specific lectin. Biochem. J. 238: 683-689.
42. Wasano, K., and Y. Hirakawa. 1997. Recombinant galectin-1 recognizes mucin and epithelial cell surface glycocalyces of gastrointestinal tract. J. Histochem. Cytochem. 45: 275-283.
43. He, L., S. Andre, H. C. Siebert, H. Helmholz, B. Niemeyer, and H. J. Gabius. 2003. Detection of ligand- and solvent-induced shape alterations of cell-growth-regulatory human lectin galectin-1 in solution by small angle neutron and x-ray scattering. Biophys. J. 85: 511-524.
44. Andre, S., H. Kaltner, M. Lensch, R. Russwurm, H. C. Siebert, C. Fallsehr, E. Tajkhorshid, A. J. Heck, M. von Knebel Doeberitz, H. J. Gabius, and J. Kopitz. 2005. Determination of structural and functional overlap/divergence of five proto-type galectins by analysis of the growth-regulatory interaction with ganglioside GM1 in silico and in vitro on human neuroblastoma cells. Int. J. Cancer 114: 46-57.
45. Galvan, M., S. Tsuboi, M. Fukuda, and L. G. Baum. 2000. Expression of a specific glycosyltransferase enzyme regulates T cell death mediated by galectin-1. J. Biol. Chem. 275: 16730-16737.
46. Hahn, H. P., M. Pang, J. He, J. D. Hernandez, R. Y. Yang, L. Y. Li, X. Wang, F. T. Liu, and L. G. Baum. 2004. Galectin-1 induces nuclear translocation of endonuclease G in caspase- and cytochrome c-independent T cell death. Cell Death Differ. 11: 1277-1286.
47. 2+ to galectin-1-induced exposure of phosphatidylserine on activated neutrophils. J. Biol. Chem. 280: 28623-28631.
48. van der Leij, J., A. van den Berg, T. Blokzijl, G. Harms, H. van Goor, P. Zwiers, R. van Weeghel, S. Poppema, and L. Visser. 2004. Dimeric galectin-1 induces IL-10 production in T-lymphocytes: an important tool in the regulation of the immune response. J. Pathol. 204: 511-518.
49. Massa, S. M., D. N. Cooper, H. Leffler, and S. H. Barondes. 1993. L-29, an endogenous lectin, binds to glycoconjugate ligands with positive cooperativity. Biochemistry 32: 260-267.
50. Stowell, S. R., M. Dias-Baruffi, L. Penttila, O. Renkonen, A. K. Nyame, and R. D. Cummings. 2004. Human galectin-1 recognition of poly-N-acetyllactosamine and chimeric polysaccharides. Glycobiology 14: 157-167.
51. Zimmerman, G. A., T. M. McIntyre, and S. M. Prescott. 1985. Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J. Clin. Invest. 76: 2235-2246.
52. Nicoletti, I., G. Migliorati, M. C. Pagliacci, F. Grignani, and C. Riccardi. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139: 271-279.
53. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55-63.
54. Bochner, B. S., R. A. Alvarez, P. Mehta, N. V. Bovin, O. Blixt, J. R. White, and R. L. Schnaar. 2005. Glycan array screening reveals a candidate ligand for siglec-8. J. Biol. Chem. 280: 4307-4312.
55. Blixt, O., S. Head, T. Mondala, C. Scanlan, M. E. Huflejt, R. Alvarez, M. C. Bryan, F. Fazio, D. Calarese, J. Stevens, et al. 2004. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc. Natl. Acad. Sci. USA 101: 17033-17038.
56. Leppanen, A., S. Stowell, O. Blixt, and R. D. Cummings. 2005. Dimeric galectin-1 binds with high affinity to α2,3-sialylated and non-sialylated terminal N-acetyllactosamine units on surface-bound extended glycans. J. Biol. Chem. 280: 5549-5562.
57. Hirabayashi, J., T. Hashidate, Y. Arata, N. Nishi, T. Nakamura, M. Hirashima, T. Urashima, T. Oka, M. Futai, W. E. Muller, et al. 2002. Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim. Biophys. Acta 1572: 232-254.
58. + T cells with an epithelial cell lectin, galectin-4, contributes to exacerbation of intestinal inflammation. Immunity 20: 681-693.
59. + T cells. Blood 108: 4094-4101.
60. Kopitz, J., C. von Reitzenstein, S. Andre, H. Kaltner, J. Uhl, V. Ehemann, M. Cantz, and H. J. Gabius. 2001. Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3. J. Biol. Chem. 276: 35917-35923.
61. Hernandez, J. D., J. T. Nguyen, J. He, W. Wang, B. Ardman, J. M. Green, M. Fukuda, and L. G. Baum. 2006. Galectin-1 binds different CD43 glycoforms to cluster CD43 and regulate T cell death. J. Immunol. 177: 5328-5336.
62. Valenzuela, H. F., K. E. Pace, P. V. Cabrera, R. White, K. Porvari, H. Kaija, P. Vihko, and L. G. Baum. 2007. O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1. Cancer Res. 67: 6155-6162.
63. Camby, I., M. Le Mercier, F. Lefranc, and R. Kiss. 2006. Galectin-1: a small protein with major functions. Glycobiology 16: 137R-157R.
64. Cherayil, B. J., S. J. Weiner, and S. Pillai. 1989. The Mac-2 antigen is a galactose-specific lectin that binds IgE. J. Exp. Med. 170: 1959-1972.
65. Fernandez, G. C., J. M. Ilarregui, C. J. Rubel, M. A. Toscano, S. A. Gomez, M. B. Bompadre, M. A. Isturiz, G. A. Rabinovich, and M. S. Palermo. 2004. Galectin-3 and soluble fibrinogen act in concert to modulate neutrophil activation and survival: involvement of alternative MAPK-pathways. Glycobiology 15: 519-527.
66. Toscano, M. A., G. A. Bianco, J. M. Ilarregui, D. O. Croci, J. Correale, J. D. Hernandez, N. W. Zwirner, F. Poirier, E. M. Riley, L. G. Baum, and G. A. Rabinovich. 2007. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat. Immunol. 8: 825-834.
67. Moore, K. W., A. O'Garra, R. de Waal Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11: 165-190.
68. de Waal Malefyt, R., J. Haanen, H. Spits, M. G. Roncarolo, A. te Velde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, and J. E. de Vries. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174: 915-924.
69. Toscano, M. A., A. G. Commodaro, J. M. Ilarregui, G. A. Bianco, A. Liberman, H. M. Serra, J. Hirabayashi, L. V. Rizzo, and G. A. Rabinovich. 2006. Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses. J. Immunol. 176: 6323-6332.
70. Juszczynski, P., J. Ouyang, S. Monti, S. J. Rodig, K. Takeyama, J. Abramson, W. Chen, J. L. Kutok, G. A. Rabinovich, and M. A. Shipp. 2007. The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma. Proc. Natl. Acad. Sci. USA 104: 13134-13139.
71. Asseman, C., S. Mauze, M. W. Leach, R. L. Coffman, and F. Powrie. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190: 995-1004.
72. Blois, S. M., J. M. Ilarregui, M. Tometten, M. Garcia, A. S. Orsal, R. Cordo-Russo, M. A. Toscano, G. A. Bianco, P. Kobelt, B. Handjiski, et al. 2007. A pivotal role for galectin-1 in fetomaternal tolerance. Nat. Med. 13: 1450-1457.
73. Offner, H., B. Celnik, T. S. Bringman, D. Casentini-Borocz, G. E. Nedwin, and A. A. Vandenbark. 1990. Recombinant human β-galactoside binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 28: 177-184.
74. Levi, G., and V. I. Teichberg. 1983. Selective interactions of electrolectins from eel electric organ and mouse thymus with mouse immature thymocytes. Immunol. Lett. 7: 35-39.
75. Meszaros, A. J., J. S. Reichner, and J. E. Albina. 1999. Macrophage phagocytosis of wound neutrophils. J. Leukocyte Biol. 65: 35-42.
76. Kakimoto, K., A. Matsukawa, M. Yoshinaga, and H. Nakamura. 1995. Suppressive effect of a neutrophil elastase inhibitor on the development of collagen-induced arthritis. Cell. Immunol. 165: 26-32.
77. Carden, D. L., and R. J. Korthuis. 1996. Protease inhibition attenuates microvascular dysfunction in postischemic skeletal muscle. Am. J. Physiol. 271: H1947-H1952.
78. Kawabata, K., T. Hagio, S. Matsumoto, S. Nakao, S. Orita, Y. Aze, and H. Ohno. 2000. Delayed neutrophil elastase inhibition prevents subsequent progression of acute lung injury induced by endotoxin inhalation in hamsters. Am. J. Respir. Crit. Care Med. 161: 2013-2018.
79. Pace, K. E., H. P. Hahn, M. Pang, J. T. Nguyen, and L. G. Baum. 2000. CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death. J. Immunol. 165: 2331-2334.